Caxton Associates (New York)’s KORU Medical Systems KRMD Stock Holding History

Caxton Associates (New York)’s Portfolio KRMD Stock Details KRMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-10,291	Closed	-$31K	–	614
2021 Q4	$31K	Sell	10,291 -10,507	-51%	-$32.2K	﹤0.01%	541
2021 Q3	$59K	Hold	20,798	–	–	0.01%	431
2021 Q2	$96K	Sell	20,798 -3,900	-16%	-$15.3K	0.01%	452
2021 Q1	$87K	Buy	+24,698	New	+$107K	0.01%	403
2020 Q4	–	Sell	-32,782	Closed	-$237K	–	239
2020 Q3	$237K	Sell	32,782 -10,157	-24%	-$90.1K	0.02%	234
2020 Q2	$386K	Buy	42,939 +8,676	+25%	+$87.7K	0.03%	190
2020 Q1	$257K	Buy	+34,263	New	+$230K	0.05%	295

Other funds holding KRMD

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

ACM

Archon Capital Management Seattle, Washington $177M AUM 108.05% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ACM

Altium Capital Management New York $42M AUM

AFG

Albion Financial Group Salt Lake City, Utah $1.73B AUM 20.99% 1-Year Est. Return

PHP

Parkman Healthcare Partners Stamford, Connecticut $970M AUM 79.46% 1-Year Est. Return

272 Capital Dallas, Texas $40M AUM 150.07% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

MIM

Meros Investment Management Dallas, Texas $231M AUM 35.94% 1-Year Est. Return

Caxton Associates (New York)'s KRMD Position: Q1 2022 in Review

Caxton Associates (New York) sold out of KORU Medical Systems (KRMD) in Q1 2022, closing a stake of 10,291 shares — an estimated $31K sold.

Caxton Associates (New York) first reported a position in KRMD in Q1 2020 and held it in 7 quarters. The position peaked at $386K in Q2 2020. 36 funds tracked by Wall St. Rank hold KRMD as of Q1 2022.

Caxton Associates (New York) reported no remaining KORU Medical Systems position as of Q1 2022 after selling out during the quarter.
Caxton Associates (New York) sold 10,291 KORU Medical Systems shares in Q1 2022, an estimated $31K.
Caxton Associates (New York) first reported a position in KORU Medical Systems in Q1 2020 and held it in 7 quarters.
Caxton Associates (New York)'s KORU Medical Systems position peaked at $386K in Q2 2020.
36 funds tracked by Wall St. Rank held KORU Medical Systems as of Q1 2022.

Based on Caxton Associates (New York)'s 13F filing for Q1 2022, filed 16 May 2022.